Results 201 to 210 of about 7,554 (256)

Hepar

2007
exaly   +2 more sources

Hepar

2015
exaly   +2 more sources

Hepar-on-a-sensor-platform with hybridization chain reaction amplification strategy to intuitively monitor the hepatoxicity of natural compounds.

Acta Biomaterialia, 2023
The irrational use of natural compounds in the treatment of diseases can lead to serious side effects, especially hepatoxicity, and its toxic effects are usually cumulative and imperceptible.
Wen-Hui Qian, Guangming Gong, H. Su, Yang Zhao, Weijin Fu, Yuting Wang, Wenwen Ji, Xuetong Sun, Bei Zhang, Lijuan Ma, Jian-Ting Li, Xiang-Ying Zhang, Su Li, Enze Sheng, Yin Lu, Dong Zhu   +15 more
semanticscholar   +1 more source

Hepar Sulphuris in Cutaneous Diseases

New England Journal of Medicine
exaly   +2 more sources

Efek Ekstrak Kulit Durian (Durio zibethinus) Terhadap Kadar Glukosa Darah dan Histopatologi Hepar Tikus Wistar yang Diinduksi Aloksan

JUKEJ : Jurnal Kesehatan Jompa
Kulit durian (Durio zibethinus) kaya flavonoid yang berpotensi menurunkan glukosa darah dan melindungi hepar, namun bukti in vivo terstandar masih terbatas.
Risna Pebriani Hura, Andre Budi, Suandy Suandy   +2 more
semanticscholar   +1 more source

3D-Bioprinted Hepar-on-a-Chip Implanted in Graphene-Based Plasmonic Sensors.

ACS Sensors
Precise three-dimensional (3D) bioprinting designs enable the fabrication of unique structures for 3D-cell culture models. There is still an absence of real-time detection tools to effectively track in situ 3D-cell performance, hindering a comprehensive ...
Yuting Wang, Dan-Dan Ma, Qi-Jia Zhang, Wen-Hui Qian, Dongbing Liang, Jiachen Shen, Xing Pan, Chao Wang, Enze Sheng, Dong Zhu   +9 more
semanticscholar   +1 more source

Diagnosis Supporting Rules of the Hepar System

2001
The “Hepar” system comprises a clinical database and the shell of procedures that aim at data analysis and the support of diagnosis. The database consists of hepatological patient cases. Each case is described by about 200 medical findings and histopathologically verified diagnosis. The diagnosis supporting rules of “Hepar&
Leon Bobrowski, Hanna Wasyluk
openaire   +3 more sources

Effect of hepar‐protecting Wuzhi capsule on pharmacokinetics and dose‐effect character of tacrolimus in healthy volunteers

Biopharmaceutics & drug disposition, 2022
Wuzhi capsule (WZC), a preparation of Fructus Schisandra sphenanthera extract, has been used widely for the treatment of viral and drug‐induced hepatitis in China.
Fei Teng, Wei Wang, Wei-Yue Zhang, Jiani Chen, Shi-Yi Liu, Yun-Lei Yun, Jia Yi, Mingming Li, Hua Wei, Wansheng Chen   +9 more
semanticscholar   +1 more source

Hepar Lobatum Carcinomatosus

2014
Clinical History: A 37-year-old woman was admitted with weight loss, recent painful hepatomegaly and altered hepatic function with cytolysis and non-icteric cholestasis. Two years ago, she had been submitted to a right mastectomy, radio-chemotherapy and tamoxifen for a bre...
openaire   +1 more source

Extension of the Hepar II Model to Multiple-Disorder Diagnosis

2000
The Hepar II system is based on a Bayesian network model of a subset of the domain of hepatology in which the structure of the network is elicited from an expert diagnostician and the parameters are learned from a database of medical cases. The model follows the assumption made in the database that each patient case is diagnosed with a single disorder,
Agnieszka Onisko, Marek Druzdezel, Hanna Wasyluk   +2 more
openaire   +2 more sources